Series A Biopharma Companies

Broad-spectrum antiviral drug development

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

Acclinate leverages sustained engagement and AI-driven insights to empower communities to take actions for better health.

Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.

Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Stane's objective is to mobilize collective wisdom to improve community medicine's performance.

CCM Biosciences operates as a biopharmaceutical company.

Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs.

Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

Mantis biotech builds a unified biomedical device testing and regulatory platform

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.